Dr. Robert J. Rosen Recognized as Castle Connolly Top Doctor for 27th Consecutive Year
TL;DR
Dr. Robert J. Rosen's 27-year Top Doctor recognition offers patients a competitive advantage in accessing world-renowned expertise for complex vascular conditions.
Dr. Rosen's selection process involves peer nomination and rigorous evaluation of medical education, training, hospital appointments, and disciplinary history by Castle Connolly.
Dr. Rosen's minimally invasive techniques and global patient care advance medical treatment, improving quality of life for those with complex vascular disorders worldwide.
Dr. Rosen has performed over 70,000 procedures and holds multiple patents while developing techniques now commonly used in interventional radiology.
Found this article helpful?
Share it with your network and spread the knowledge!

Dr. Robert J. Rosen, an interventional radiologist and endovascular surgeon, has been named a 2025 Castle Connolly Top Doctor, marking his 27th consecutive year receiving this prestigious designation. This recognition places him among an elite group, as only 7 percent of the nation's licensed physicians are selected annually as Castle Connolly Top Doctors for their specialties in their regions. The significance of this extended recognition underscores the sustained excellence and peer respect that defines exceptional medical careers.
As AVM Center Director at the Lenox Hill Heart and Vascular Institute in New York, Dr. Rosen evaluates and treats complex vascular conditions, with international recognition for managing congenital vascular malformations in both children and adults. His practice receives patient referrals from around the world for these challenging disorders, demonstrating the global impact of his specialized expertise. His medical focus extends to treating aortic aneurysms, atherosclerosis, hepatic tumors, and uterine fibroids, covering a broad spectrum of vascular and interventional conditions.
Throughout his career, Dr. Rosen has performed over 70,000 interventional and endovascular procedures, developing techniques and instrumentation now in common use throughout the medical community. His procedural expertise is applied to minimally invasive treatments for congenital vascular malformations, aortic aneurysms, peripheral artery disease, liver cancer, and uterine fibroids, representing significant advancements in patient care that reduce recovery times and improve outcomes. The Castle Connolly selection process, detailed at https://www.castleconnolly.com, involves nominations by peer physicians and selection by a physician-led research team, ensuring that recognition reflects genuine professional respect and clinical excellence.
Dr. Rosen's contributions to medical literature include over 100 original scientific papers, two textbooks, and numerous book chapters, complemented by several patents for medical instrumentation. As an esteemed educator, he lectures internationally and has served as a visiting professor at multiple institutions. Dr. Rosen is a Fellow of the Society for Interventional Radiology and maintains membership in the Alpha Omega Alpha Honor Medical Society, the Radiological Society of North America, and the Cardiovascular Council of the American Heart Association. The Castle Connolly selection criteria, available through their official resources at https://www.castleconnolly.com, emphasize medical education, training, hospital appointments, and disciplinary histories, with doctors prohibited from paying for selection, ensuring the integrity of the recognition process.
This sustained recognition matters because it validates decades of consistent clinical excellence in a rapidly evolving medical specialty. The implications extend beyond individual achievement to influence medical education, procedural innovation, and global standards of care. Dr. Rosen's work in developing minimally invasive techniques has transformed treatment approaches for numerous conditions, while his international referrals demonstrate how specialized expertise transcends geographical boundaries to benefit patients worldwide. The rigorous selection process maintained by Castle Connolly provides patients and medical institutions with reliable indicators of physician quality, making such sustained recognition particularly meaningful in healthcare decision-making.
Curated from 24-7 Press Release
